PTCT Sale Disclosure
Schmertzler Michael · SEC Form 4 · Filed Sep 11, 2026
Sale
Calculated transaction value
$39.28K
Schmertzler Michael Director
PTCT
PTC Therapeutics
PTCT
Transaction date
Sep 9, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 2 days later
PTCT daily price context
Close on/before transaction
$67.57
Sep 9, 2026
Close before public filing
$67.37
Sep 10, 2026
Return since public filing
-1.94%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 572 shares @ $68.67
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001288952-26-000008
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.35M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ptc Therapeutics, Inc. PTCT | Sale | Sep 10, 2026 | $673.4K |
| Ptc Therapeutics, Inc. PTCT | Sale | Sep 9, 2026 | $639.12K |
| Ptc Therapeutics, Inc. PTCT Current | Sale | Sep 9, 2026 | $39.28K |